ASC-J9 Size:Solid 10 mg 5-trihydroxy-6-((((2R

5-trihydroxy-6-((((2R

Smiles: C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@@H](CO)O[C@H]2O[C@@]23C[C@]4(CC2=C)CC[C@@H]2[C@@](C)(CCC[C@@]2(C)[C@@H]4CC3)C(=O)O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O

physico-chemical properties

Chemical Name: 3-{2-[4-(6-fluoro-1

4-d]pyrazol-5-yl]benzoic acid

ASC-J9 Size:Solid 10 mg 5-trihydroxy-6-((((2RASC J9, also known as GO Y025 and Dimethylcurcumin, is an AR degradation enhancer ASC J9 suppresses castration resistant prostate cancer growth through degradation of full length and splice variant androgen receptors. ASC J9 suppresses renal cell carcinoma progression by targeting an androgen receptor dependent HIF2 VEGF signaling pathway. ASC J9 treatment enhanced BCG efficacy to suppress bladder cancer cell proliferation via increasing the